drugset / Trial / NCT01459679

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

NCT01459679 ↗

Phase 3 Terminated 1721 enrolled American-European Congress of Ophthalmic Surgery
RandomizedParallel-groupOpen-labelTreatment

Summary

The objectives of this study are to evaluate and compare the safety and efficacy of three treatment regimens for corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System in impeding the progression of, and/or reducing maximum corneal curvature.

Timeline

Start
2012-07
Primary completion
2016-01
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator riboflavin ophthalmic solution Unknown — Other